291 related articles for article (PubMed ID: 21412389)
41. Combination antiretroviral therapy.
Domingo P; Vidal F
Expert Opin Pharmacother; 2011 May; 12(7):995-8. PubMed ID: 21434758
[TBL] [Abstract][Full Text] [Related]
42. Cardiovascular implications of HIV-induced dyslipidemia.
Giannarelli C; Klein RS; Badimon JJ
Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
[TBL] [Abstract][Full Text] [Related]
43. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.
Tarr PE; Rotger M; Telenti A
Pharmacogenomics; 2010 Apr; 11(4):587-94. PubMed ID: 20350140
[TBL] [Abstract][Full Text] [Related]
44. Lipid management in patients who have HIV and are receiving HIV therapy.
Aberg JA
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):207-22. PubMed ID: 19217520
[TBL] [Abstract][Full Text] [Related]
45. Antiretroviral therapy-associated diseases are common in the long-term.
Lanzafame M; Lattuada E; Zoppini G; Vento S
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
[No Abstract] [Full Text] [Related]
46. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
[TBL] [Abstract][Full Text] [Related]
47. Dyslipidemia in HIV-infected individuals.
Sprinz E; Lazzaretti RK; Kuhmmer R; Ribeiro JP
Braz J Infect Dis; 2010; 14(6):575-88. PubMed ID: 21340298
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of lipid elevations associated with the treatment of patients with HIV infection.
Piliero PJ
MedGenMed; 2003 Jun; 5(2):1. PubMed ID: 14603100
[TBL] [Abstract][Full Text] [Related]
49. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
Kotler DP
J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S79-85. PubMed ID: 18725816
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular risks of antiretroviral therapies.
Mondy K; Tebas P
Annu Rev Med; 2007; 58():141-55. PubMed ID: 17217329
[TBL] [Abstract][Full Text] [Related]
51. [HIV infection in France in 2012: reality, risks and challenges for a chronic multisystem disease].
Blot M; Piroth L
Rev Mal Respir; 2012 Jun; 29(6):785-92. PubMed ID: 22742465
[TBL] [Abstract][Full Text] [Related]
52. [Hypertension, HIV infection, and highly active antiretroviral therapy].
Bernardino de la Serna JI; Zamora FX; Montes ML; García-Puig J; Arribas JR
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):32-7. PubMed ID: 19409669
[TBL] [Abstract][Full Text] [Related]
53. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
[TBL] [Abstract][Full Text] [Related]
54. A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management.
Neto MG; Zwirtes R; Brites C
Braz J Infect Dis; 2013; 17(6):691-700. PubMed ID: 23916459
[TBL] [Abstract][Full Text] [Related]
55. [Is dyslipidemia a risk factor in patients treated with antiretroviral drugs?].
Soska V
Vnitr Lek; 2008 Feb; 54(2):135-6. PubMed ID: 23687702
[No Abstract] [Full Text] [Related]
56. [Psoriasis and HIV infection].
Leal L; Ribera M; Daudén E
Actas Dermosifiliogr; 2008 Dec; 99(10):753-63. PubMed ID: 19091213
[TBL] [Abstract][Full Text] [Related]
57. Management of lipid disorders in patients living with HIV.
Myerson M; Malvestutto C; Aberg JA
J Clin Pharmacol; 2015 Sep; 55(9):957-74. PubMed ID: 25651539
[TBL] [Abstract][Full Text] [Related]
58. Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
Boyle BA; Cohen CJ; DeJesus E; Elion R; Frank I; Moyle GJ; Sax PE
AIDS Read; 2009 Apr; 19(4):158-60. PubMed ID: 19388184
[No Abstract] [Full Text] [Related]
59. HIV and coronary heart disease: time for a better understanding.
Boccara F; Lang S; Meuleman C; Ederhy S; Mary-Krause M; Costagliola D; Capeau J; Cohen A
J Am Coll Cardiol; 2013 Feb; 61(5):511-23. PubMed ID: 23369416
[TBL] [Abstract][Full Text] [Related]
60. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
